Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
Julphar
Fuji
McKesson
McKinsey
US Army
Medtronic
Colorcon
Queensland Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: RE36418

« Back to Dashboard

Summary for Patent: RE36418
Title: Contrast media comprising a non-ionic contrast agent with low levels of sodium and calcium ions
Abstract:The physiological acceptability of contrast media, especially media for use in angiography, may be enhanced by inclusion of sub-plasma levels of sodium and calcium and, optionally, potassium and/or magnesium, for example 30 mM Na, 0.15 mM Ca, 0.9 mM K and 0.1 mM Mg.
Inventor(s): Almen; Torsten (Malmo, SE), Baath; Lars (Malmo, SE), Jynge; Per (Trondheim, NO), Oksendal; Audun Nesheim (Oslo, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Application Number:08/616,245
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent RE36418

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE36418

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
90 200580Mar 09, 1990
United Kingdom90 20091Sep 14, 1990

International Patents Family Members for US Patent RE36418

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 141519 ➤ Sign Up
Australia 645544 ➤ Sign Up
Australia 7345191 ➤ Sign Up
Canada 2076861 ➤ Sign Up
China 1055864 ➤ Sign Up
China 1056058 ➤ Sign Up
Czechoslovakia 9100619 ➤ Sign Up
Czech Republic 285071 ➤ Sign Up
Germany 69121562 ➤ Sign Up
Denmark 0521880 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
McKesson
Express Scripts
Boehringer Ingelheim
Teva
US Department of Justice
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot